Topic: Method Development

03 August 2026

Case study: Verification of SAX method selectivity using 2D-LC-MS for peak purity assessment of oligonucleotide APIs

Accurate analytical characterization is essential throughout oligonucleotide development, supporting impurity profiling, stability assessment, and ultimately the delivery of…

20 July 2026

API contract manufacturing: Process, benefits, and partner selection

Manufacturing active pharmaceutical ingredients (APIs) is a complex undertaking that requires specialized process knowledge, advanced manufacturing capabilities, and…

21 May 2026

Webinar 2D LC/MS: Peak purity determination for denaturing SAX oligonucleotide methods

  About the webinar Oligonucleotides are emerging new therapeutic entities, and reliable selective analytical methods to determine their…

20 April 2026

GLP-1 Demand: What it means for peptide manufacturers

GLP-1 receptor agonists are transforming peptide manufacturing. For decades, peptide APIs were typically produced at kilogram scale for…

15 April 2026

A Step-By-Step Guide to Analytical Method Development and Validation

Analytical method development and validation are essential foundations of pharmaceutical and biotechnology workflows. These processes ensure that analytical…

05 November 2025

The importance of time to market for New Chemical Entities

In the highly competitive pharmaceutical industry, time to market plays a pivotal role in determining the success of…

24 June 2025

FMEA: A process for risk assessment in the pharmaceutical industry

The pharmaceutical industry operates under strict regulations to protect patient safety and maintain high-quality standards. Even small mistakes…